Opportunistic. May trigger the board to start merger talks with Sigma again. Not sure if pharmacist members of API groups and profession generally keen on Wesfarmers entry into this space. Thin end of the wedge into pharmacy ownership by big corporates as it potentially reduces to case for retention of current rules!
